Kemnay Advisory Services’s Rapport Therapeutics RAPP Stock Holding History
Bought
Maintained
Sold
Other funds holding RAPP
Kemnay Advisory Services's RAPP Position: Q3 2026 in Review
Kemnay Advisory Services opened a new position in Rapport Therapeutics (RAPP) in Q3 2026: 351 shares worth $11.8K. The stake represents ﹤0.01% of the portfolio and ranks #707 among its holdings.
169 funds tracked by Wall St. Rank hold RAPP as of Q3 2026.
- Kemnay Advisory Services held 351 shares of Rapport Therapeutics worth $11.8K as of Q3 2026.
- Rapport Therapeutics was a new Kemnay Advisory Services position in Q3 2026.
- Rapport Therapeutics made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q3 2026, its #707 holding.
- 169 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q3 2026.
Based on Kemnay Advisory Services's 13F filing for Q3 2026, filed 16 Nov 2026.